Page URL:

Prioritising Patient Safety: How to Minimise Risk in Fertility Treatment

Progress Educational Trust
Event to be held online, via Zoom Video Webinars
9 February 2022 5.30pm-7pm (GMT)

Speakers at the Progress Educational Trust's FREE-to-attend public event 'Prioritising Patient Safety: How to Minimise Risk in Fertility Treatment', being held online on Wednesday 9 February 2022A free-to-attend online event about the risks posed by IVF and related treatment, and how best to deal with these risks.

The event will be chaired by Sarah Norcross (Director of PET), with speakers including:

  • Professor Abha Maheshwari (Clinical Director of the Aberdeen Fertility Centre)

  • Dr Michael Rimmer (Specialist Registrar in Obstetrics and Gynaecology, and Clinical Research Training Fellow at the University of Edinburgh)

  • Professor Ashley Moffett (Emeritus Professor of Reproductive Immunology at the University of Cambridge)

  • Professor Marian Knight (Professor of Maternal and Child Population Health at the University of Oxford)

  • Rachel Cutting (Director of Compliance and Information at the Human Fertilisation and Embryology Authority)

This event is produced by the Progress Educational Trust (PET) in partnership with the Scottish Government.

In the decades since the world's first IVF babies were born in the UK, fertility treatment has gone from experimental to routine. More people in the UK now undergo IVF treatment every year than have their appendix removed.

Fertility treatment can only be provided legally in the UK by clinics that are licensed and inspected by the sector's specialist regulator, the Human Fertilisation and Embryology Authority. Treatment at these clinics is for the most part very safe, and most fertility patients are no more likely to experience problems with health or pregnancy than people who conceive naturally.

However, most medical procedures are accompanied by some level of risk, and fertility treatment is no exception. At this event, experts will explore particular risks associated with aspects of fertility treatment, and will discuss how best to monitor and minimise these risks.

Issues discussed will include:

  • Ovarian hyperstimulation syndrome (OHSS) – its causes and consequences, how it presents, and how it might be prevented.

  • Multiple pregnancy and multiple birth – how and why these might be avoided.

  • Immune treatments – risks posed by, and claims made for, fertility treatment 'add-ons' that deliberately suppress the patient's immune system.

  • COVID-19 vaccination – the merits of being vaccinated prior to embarking on fertility treatment.

If discussing this event on social media, please use the hashtag #IVFsafety

Attendees will not be audible or visible during this online event, but will still be able to put questions and comments to the speakers and chair, via a Q&A tool within Zoom Video Webinars.